» Articles » PMID: 31877626

Caveolin As a Universal Target in Dermatology

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2019 Dec 28
PMID 31877626
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Caveolin-1 is strongly expressed in different dermal and subdermal cells and physically interacts with signaling molecules and receptors, among them with transforming growth factor beta (TGF-β), matrix metalloproteinases, heat shock proteins, toll-like and glucocorticoid receptors. It should therefore be heavily involved in the regulation of cellular signaling in various hyperproliferative and inflammatory skin conditions. We provide an overview of the role of the caveolin-1 expression in different hyperproliferative and inflammatory skin diseases and discuss its possible active involvement in the therapeutic effects of different well-known drugs widely applied in dermatology. We also discuss the possible role of caveolin expression in development of the drug resistance in dermatology. Caveolin-1 is not only an important pathophysiological factor in different hyperproliferative and inflammatory dermatological conditions, but can also serve as a target for their treatment. Targeted regulation of caveolin is likely to serve as a new treatment strategy in dermatology.

Citing Articles

A Retrospective Pragmatic Two-Center Clinical Study to Evaluate the Clinical Outcome of Triple-Frequency Ultrasound in the Treatment of Mild-to-Severe Acne Vulgaris.

Chervinskaya I, Gaidash N, Kruglikov I J Cosmet Dermatol. 2024; 24(2):e16672.

PMID: 39552138 PMC: 11845943. DOI: 10.1111/jocd.16672.


Downregulation of Caveolae-Associated Proteins in Psoriasis: A Case Series Study.

Lin D, Abujamra B, Revah S, Nattkemper L, Morrison B, Romanelli P JID Innov. 2024; 4(2):100265.

PMID: 38445230 PMC: 10914522. DOI: 10.1016/j.xjidi.2024.100265.


Interactions between calcium regulatory pathways and mechanosensitive channels in airways.

Yao Y, Borkar N, Zheng M, Wang S, Pabelick C, Vogel E Expert Rev Respir Med. 2023; 17(10):903-917.

PMID: 37905552 PMC: 10872943. DOI: 10.1080/17476348.2023.2276732.


Involvement of caveolin-1 in skin diseases.

Takamura N, Yamaguchi Y Front Immunol. 2022; 13:1035451.

PMID: 36532050 PMC: 9748611. DOI: 10.3389/fimmu.2022.1035451.


Phenotypical Conversions of Dermal Adipocytes as Pathophysiological Steps in Inflammatory Cutaneous Disorders.

Kruglikov I, Zhang Z, Scherer P Int J Mol Sci. 2022; 23(7).

PMID: 35409189 PMC: 8998946. DOI: 10.3390/ijms23073828.


References
1.
Kruglikov I, Zhang Z, Scherer P . Caveolin-1 in skin aging - From innocent bystander to major contributor. Ageing Res Rev. 2019; 55:100959. PMC: 6783389. DOI: 10.1016/j.arr.2019.100959. View

2.
Palacios-Ortega S, Varela-Guruceaga M, Milagro F, Martinez J, de Miguel C . Expression of Caveolin 1 is enhanced by DNA demethylation during adipocyte differentiation. status of insulin signaling. PLoS One. 2014; 9(4):e95100. PMC: 3994010. DOI: 10.1371/journal.pone.0095100. View

3.
Shindo T, Ito K, Ogata T, Hatanaka K, Kurosawa R, Eguchi K . Low-Intensity Pulsed Ultrasound Enhances Angiogenesis and Ameliorates Left Ventricular Dysfunction in a Mouse Model of Acute Myocardial Infarction. Arterioscler Thromb Vasc Biol. 2016; 36(6):1220-9. DOI: 10.1161/ATVBAHA.115.306477. View

4.
Sohn J, Lin H, Fritch M, Tuan R . Influence of cholesterol/caveolin-1/caveolae homeostasis on membrane properties and substrate adhesion characteristics of adult human mesenchymal stem cells. Stem Cell Res Ther. 2018; 9(1):86. PMC: 5883280. DOI: 10.1186/s13287-018-0830-4. View

5.
Kruglikov I, Scherer P . Caveolin-1 as a pathophysiological factor and target in psoriasis. NPJ Aging Mech Dis. 2019; 5:4. PMC: 6363785. DOI: 10.1038/s41514-019-0034-x. View